FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
17 letters match. Newest first.
-
BiologicsBlue Horizon International, LLC
FDA warned Blue Horizon International over unapproved stem cell and exosome biologics marketed for serious diseases without a license.
High risk -
BiologicsConceive Fertility Center
FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.
High risk -
BiologicsCelularity, Inc
FDA warns Celularity that Interfyl is an unapproved new drug and unlicensed biological product marketed for orthopedic and wound uses.
High risk -
BiologicsBioXtek LLC
FDA says BioXtek's amniotic membrane products are unapproved new drugs and unlicensed biological products.
High risk -
BiologicsNew Life Medical Services, LLC
FDA says New Life Medical Services sells unapproved umbilical-cord, amniotic-fluid, and exosome products as drugs.
High risk -
BiologicsNuVida Medical LLC
FDA says NuVida Medical sells unapproved, unlicensed tissue products for non-homologous wound care uses.
High risk -
BiologicsPlatinum Biologics LLC
FDA says Platinum Biologics sells unapproved umbilical cord and exosome biologics without required licenses or approvals.
High risk -
BiologicsInnate Healthcare Institute
FDA warned Arizona clinic Innate Healthcare Institute for selling unapproved umbilical cord stem cells marketed to treat autism.
High risk -
BiologicsSkye Biologics Holdings LLC
FDA warns Skye Biologics its umbilical cord-derived BioECM products are unapproved drugs and unlicensed biologics, made with serious manufacturing (CGMP) failures.
High risk -
BiologicsEvolutionary Biologics Inc.
FDA warned Evolutionary Biologics that its exosome and umbilical-cord products are unapproved new drugs and unlicensed biologics sold with disease-treatment claims.
High risk -
BiologicsMother Stem Institute, Corp.
FDA warns Mother Stem Institute over unapproved fat-derived SVF 'stem cell' biologic marketed for serious diseases.
High risk -
BiologicsNeobiosis, LLC
FDA warns Neobiosis over unapproved amniotic fluid and umbilical cord products and serious manufacturing quality failures.
High risk -
BiologicsSignature Biologics, LLC
FDA cited Signature Biologics for unapproved, unlicensed Signature Cord and serious sterile manufacturing failures.
High risk -
BiologicsRow1 Inc. dba Regenative Labs
FDA warned Regenative Labs that its umbilical cord products are unlicensed drugs, made under serious sterility and manufacturing failures.
High risk -
BiologicsVitti Labs, LLC
FDA warns Vitti Labs over unapproved umbilical cord and amniotic membrane products and sterile manufacturing failures.
High risk -
BiologicsRe-Gen Active Lab, Inc.
FDA warned Re-Gen Active Lab over unapproved amniotic/umbilical cord injectables and serious sterility failures.
High risk -
BiologicsCooper Institute
FDA warned Houston fertility clinic Cooper Institute that it failed to test and screen oocyte donors for infectious diseases.
High risk